| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/20/2005 | WO2004098627A9 Inhibition of platelet aggregation through acyclovir and two peptide antagonists |
| 01/20/2005 | WO2004098525A9 Uses of ion channel modulating compounds |
| 01/20/2005 | WO2004098510A3 Cystic fibrosis therapy |
| 01/20/2005 | WO2004098507A3 1,3 aclyated 24-keto-vitamin d3 compounds and methods of use thereof |
| 01/20/2005 | WO2004096802A9 ANTIBIOTIC TETRAHYDRO-β-CARBOLINE DERIVATIVES |
| 01/20/2005 | WO2004096194A9 Prevention of hiv-1 infection by inhibition of rho-mediated reorganization and/or content alteration of cell membrane raft domains |
| 01/20/2005 | WO2004096129A3 Inhibitors of akt activity |
| 01/20/2005 | WO2004093788A9 Desmoglein 4 is a novel gene involved in hair growth |
| 01/20/2005 | WO2004092166A3 Cgrp receptor antagonists |
| 01/20/2005 | WO2004091614A3 Stabilized amlodipine maleate formations |
| 01/20/2005 | WO2004091486A3 Compounds for the treatment of metabolic disorders |
| 01/20/2005 | WO2004089992A8 Modified acacia and use thereof |
| 01/20/2005 | WO2004089965A3 Topiramate and processes for the preparation thereof |
| 01/20/2005 | WO2004089926A8 Genipin derivatives and uses thereof |
| 01/20/2005 | WO2004089407A3 Zwitterionic immunomodulators for the treatment of asthma and allergy |
| 01/20/2005 | WO2004089355A3 Compositions for treating microbial and parasitic infections in cattle and other animals |
| 01/20/2005 | WO2004087713A8 Salts of tricyclic inhibitors of poly(adp-ribose) polymerases |
| 01/20/2005 | WO2004087259A3 Pharmaceutical composition effective in treatment of mechanical allodynia, screening method of potential compound as said pharmaceutical composition, abd inspection method of mechanical allodynia |
| 01/20/2005 | WO2004087209A9 Preparation for sustaining therapeutically effective blood concentration of analgesic activity potentiator |
| 01/20/2005 | WO2004085448A3 Unsaturated phosphinyl-phosphonate phosphate transport inhibitors |
| 01/20/2005 | WO2004083382A3 Compositions and methods for treating hyperimmune response in the eye |
| 01/20/2005 | WO2004083208A8 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 01/20/2005 | WO2004080467A3 Method of treating and preventing hyperparathyroidism with vitamin d2 or d4 compounds |
| 01/20/2005 | WO2004080390A3 Antiprotozoal imidazopyridine compounds |
| 01/20/2005 | WO2004078163A3 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| 01/20/2005 | WO2004078139A3 Therapeutic compositions |
| 01/20/2005 | WO2004074218A3 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 01/20/2005 | WO2004073622A3 Novel therapeutic method and compositions for topical administration |
| 01/20/2005 | WO2004073601A3 Process for the preparation of hexacyclic camptothecin derivatives |
| 01/20/2005 | WO2004071398A3 Pharmaceutical patch |
| 01/20/2005 | WO2004069793A3 Novel 2-substituted cyclic amines as calcium sensing receptor modulators |
| 01/20/2005 | WO2004069213A3 Cosmetic composition comprising a 2-alkylideneaminooxyacetamide |
| 01/20/2005 | WO2004069142A3 Anti-candida agents for the treatment of prion diseases |
| 01/20/2005 | WO2004066940A3 Compositions and methods containing substituted quinolines and substituted diphenylsulfones |
| 01/20/2005 | WO2004064761A3 Therapeutically active compounds |
| 01/20/2005 | WO2004064742A9 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| 01/20/2005 | WO2004062674A3 Substituted polyamines as inhibitors of bacterial efflux pumps |
| 01/20/2005 | WO2004041207A3 Ghb treatment methods |
| 01/20/2005 | WO2004000290A8 Pharmaceutical composition |
| 01/20/2005 | WO2003099762A8 Agents and methods for the treatment of disorders associated with oxidative stress |
| 01/20/2005 | WO2003082302A9 Bioadhesive directed somatic cell therapy |
| 01/20/2005 | WO2003076443A9 Spiro compounds with npy antagonistic activity |
| 01/20/2005 | WO2003072114A8 Vascular therapeutics |
| 01/20/2005 | WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/20/2005 | WO2003062392A3 Methods of treating conditions associated with an edg receptor |
| 01/20/2005 | US20050014949 Crystal structure; drugs; comminution in dimethylacetamide; recovering; crystallization |
| 01/20/2005 | US20050014946 Substituted amino ketone compounds |
| 01/20/2005 | US20050014942 Transforming growth factor inhibitor; controllign cell differentiation, cell proliferation |
| 01/20/2005 | US20050014941 Cyanoalkylamino derivatives as protease inhibitors |
| 01/20/2005 | US20050014938 Phenyl substituted triazoles and their use as selective inhibitors of akl5 kinase |
| 01/20/2005 | US20050014849 Utilizing 1-(3',4,'5'-trimethoxyphenyl)-2-nitro-ethylene; broad spectrum; effective against drug resistant strains |
| 01/20/2005 | US20050014848 Combination of serotonin reuptake inhibitors and norephinephrine reuptake inhibitors |
| 01/20/2005 | US20050014847 Ambroxol for the treatment of chronic nociceptive pain |
| 01/20/2005 | US20050014846 Oral administration, bioavailability; no central nervous and cardiovascular side effects |
| 01/20/2005 | US20050014845 Oral administration, bioavailability; no central nervous and cardiovascular side effects |
| 01/20/2005 | US20050014844 Oral administration; bioavailability; no central nervous system or cardiovascular side effects |
| 01/20/2005 | US20050014843 Utilizing tomoxetine compound or such as n-ethyl-3-phenyl-3-(2-butylthiophenoxy)propyl-amine; attention deficit, hyperactivity, involuntary repetitive movement or sound disorders, tourette's syndrome |
| 01/20/2005 | US20050014841 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 01/20/2005 | US20050014839 Histone deacetylase inhibitors and methods of use thereof |
| 01/20/2005 | US20050014838 Triggering microvessel dilation in striated muscle utilizing either cannabinoid receptor 1 agonist or cyclooxygenase activator and increasing uptake with beta 3 adrenergic receptor agonist |
| 01/20/2005 | US20050014837 Method for treating ocular hypertension and glaucoma |
| 01/20/2005 | US20050014836 Crystalline form of nateglinide |
| 01/20/2005 | US20050014835 Agents for Treating Diseases Caused by Nonsense Mutations |
| 01/20/2005 | US20050014834 Selective anesthetic agents and methods of identifying the same |
| 01/20/2005 | US20050014832 Treatment |
| 01/20/2005 | US20050014831 Cancer, hypertension, obesity; diseases mediated by alteration of membrane structure and regulation of G-proteins or receptors |
| 01/20/2005 | US20050014830 Substances for breaking down conformation of microbes |
| 01/20/2005 | US20050014829 Sertraline compositions |
| 01/20/2005 | US20050014828 Compositions containing prodrugs of florfenicol and methods of use |
| 01/20/2005 | US20050014827 Formulations containing polyphenol derivatives; food and feed supplements; bactericidal, fungicidal and virucidal effects |
| 01/20/2005 | US20050014826 Synthesis of polyconjugated fatty acids |
| 01/20/2005 | US20050014825 Preparation and use of solidified oils |
| 01/20/2005 | US20050014823 Sprayable homogeneous solution containing local anesthetic agent, penetration enhancer, anhydrous volatile solvent and water; fast acting, simple, reliable |
| 01/20/2005 | US20050014821 Compounds and methods for treating neurodegenerative disorders |
| 01/20/2005 | US20050014820 formed via acid-catalyzed cyclization, with production of methamine end-products; for treatment of central nervous system disorders |
| 01/20/2005 | US20050014819 Prenylflavonoids, chalcone derivatives, flavonols and/or glycosides; plant extracts; foods, beverages; insulin resistance |
| 01/20/2005 | US20050014817 Fluorothiophene derivatives, process for preparing them and pharmaceutical compositions containing them |
| 01/20/2005 | US20050014816 Thiophene amino acid derivatives, process for preparing them and pharmaceutical compositions containing them |
| 01/20/2005 | US20050014815 Substituted 2-pyrrolidine-2-yl-1H-indole compounds |
| 01/20/2005 | US20050014814 Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia |
| 01/20/2005 | US20050014811 Such as 4-cyclopentylamino-benzenesulfonic acid 2-(3,4-dimethoxy-phenylamino)-1H-benzoimidazol-5-yl ester; cyclin-dependent kinase inhibitors that are aimed to be more active than flavopiridol |
| 01/20/2005 | US20050014810 Treatment or prevention of diseases involving glucagon receptors; antagonists which block the glucagon receptor is used for treating diabetes; inhibits the production of glucose in the liver; drugs with other active substance |
| 01/20/2005 | US20050014808 Combined agents for treatment of glaucoma |
| 01/20/2005 | US20050014807 Therapeutic compounds for treating dyslipidemic conditions |
| 01/20/2005 | US20050014806 Substituted isoxazoles and their use as antibiotics |
| 01/20/2005 | US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents |
| 01/20/2005 | US20050014804 Tetrazole and oxadiazolone substituted beta-amino acid derivatives |
| 01/20/2005 | US20050014803 Enzyme inhibitors |
| 01/20/2005 | US20050014801 Benzoisoselenazole derivatives with anti-inflammation, antivirus and antithrombosis activity and their use |
| 01/20/2005 | US20050014800 Vision defects; anticancer agents; antitumor agents |
| 01/20/2005 | US20050014799 In mixture with enzyme inhibitors and other active materials |
| 01/20/2005 | US20050014797 Compositions and methods to treat gastrointestinal disorders |
| 01/20/2005 | US20050014796 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 01/20/2005 | US20050014795 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/20/2005 | US20050014794 For therapy and prophylaxis of anorexia, cancer cachexia, eating disorders, age-related decline in body composition, weight gain, obesity, and diabetes mellitus |
| 01/20/2005 | US20050014793 Pyridinone derivatives for treatment of atherosclerosis |
| 01/20/2005 | US20050014791 Inhibitors of papilloma virus |
| 01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014786 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |